FLT3 inhibitor maintenance after allogeneic transplantation is associated with improved survival in FLT3-mutated AML: MRD-stratified evidence from an updated meta-analysis.

Basendwah AM, Miyashita A, Fero H, Alasmari M, Alabbas F

Open source

DOI
10.1038/s41409-026-03049-y
Published
2026 Sep 21
Container
Bone marrow transplantation
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41409-026-03049-y,
  title = {FLT3 inhibitor maintenance after allogeneic transplantation is associated with improved survival in FLT3-mutated AML: MRD-stratified evidence from an updated meta-analysis.},
  author = {Basendwah AM and Miyashita A and Fero H and Alasmari M and Alabbas F},
  year = {2026},
  journal = {Bone marrow transplantation},
  doi = {10.1038/s41409-026-03049-y},
  url = {https://doi.org/10.1038/s41409-026-03049-y}
}

RIS

TY  - JOUR
TI  - FLT3 inhibitor maintenance after allogeneic transplantation is associated with improved survival in FLT3-mutated AML: MRD-stratified evidence from an updated meta-analysis.
AU  - Basendwah AM
AU  - Miyashita A
AU  - Fero H
AU  - Alasmari M
AU  - Alabbas F
PY  - 2026
JO  - Bone marrow transplantation
DO  - 10.1038/s41409-026-03049-y
UR  - https://doi.org/10.1038/s41409-026-03049-y
ER  - 

APA

AM, B., A, M., H, F., M, A., & F, A. (2026). FLT3 inhibitor maintenance after allogeneic transplantation is associated with improved survival in FLT3-mutated AML: MRD-stratified evidence from an updated meta-analysis.. Bone marrow transplantation. https://doi.org/10.1038/s41409-026-03049-y

Source records